227 related articles for article (PubMed ID: 11437406)
1. Cellular mechanisms of bone resorption in breast carcinoma.
Hunt NC; Fujikawa Y; Sabokbar A; Itonaga I; Harris A; Athanasou NA
Br J Cancer; 2001 Jul; 85(1):78-84. PubMed ID: 11437406
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
Mancino AT; Klimberg VS; Yamamoto M; Manolagas SC; Abe E
J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200
[TBL] [Abstract][Full Text] [Related]
3. Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells.
Quinn JM; McGee JO; Athanasou NA
J Pathol; 1998 Jan; 184(1):31-6. PubMed ID: 9582524
[TBL] [Abstract][Full Text] [Related]
4. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease.
Hirayama T; Sabokbar A; Itonaga I; Watt-Smith S; Athanasou NA
J Pathol; 2001 Dec; 195(5):624-30. PubMed ID: 11745700
[TBL] [Abstract][Full Text] [Related]
5. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
[TBL] [Abstract][Full Text] [Related]
6. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
[TBL] [Abstract][Full Text] [Related]
7. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Neale SD; Smith R; Wass JA; Athanasou NA
Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
[TBL] [Abstract][Full Text] [Related]
8. RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
Lau YS; Danks L; Sun SG; Fox S; Sabokbar A; Harris A; Athanasou NA
Breast Cancer Res Treat; 2007 Sep; 105(1):7-16. PubMed ID: 17151927
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
[TBL] [Abstract][Full Text] [Related]
11. Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures.
MacDonald BR; Mundy GR; Clark S; Wang EA; Kuehl TJ; Stanley ER; Roodman GD
J Bone Miner Res; 1986 Apr; 1(2):227-33. PubMed ID: 3332553
[TBL] [Abstract][Full Text] [Related]
12. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM; Nishioka K; Yudoh K
Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
[TBL] [Abstract][Full Text] [Related]
14. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
15. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
Roux S; Quinn J; Pichaud F; Orcel P; Chastre E; Jullienne A; De Vernejoul MC
J Cell Physiol; 1996 Sep; 168(3):489-98. PubMed ID: 8816903
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
Väänänen K
Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus capsular material promotes osteoclast formation.
Lau YS; Wang W; Sabokbar A; Simpson H; Nair S; Henderson B; Berendt A; Athanasou NA
Injury; 2006 May; 37 Suppl 2():S41-8. PubMed ID: 16651071
[TBL] [Abstract][Full Text] [Related]
18. Nurse-like cells from patients with rheumatoid arthritis support the survival of osteoclast precursors via macrophage colony-stimulating factor production.
Tsuboi H; Udagawa N; Hashimoto J; Yoshikawa H; Takahashi N; Ochi T
Arthritis Rheum; 2005 Dec; 52(12):3819-28. PubMed ID: 16320327
[TBL] [Abstract][Full Text] [Related]
19. Cellular and hormonal mechanisms associated with malignant bone resorption.
Quinn JM; Matsumura Y; Tarin D; McGee JO; Athanasou NA
Lab Invest; 1994 Oct; 71(4):465-71. PubMed ID: 7526033
[TBL] [Abstract][Full Text] [Related]
20. CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems.
Liverani C; Mercatali L; Spadazzi C; La Manna F; De Vita A; Riva N; Calpona S; Ricci M; Bongiovanni A; Gunelli E; Zanoni M; Fabbri F; Zoli W; Amadori D; Ibrahim T
Bone; 2014 Sep; 66():214-22. PubMed ID: 24956020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
